Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Post-approval studies (Phase 4)UnknownNCT02616354
What this trial is testing

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

Who this might be right for
Sepsis
Southeast University, China 24
Not applicableStudy completedNCT03790631
What this trial is testing

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Who this might be right for
Beta-lactam AntibioticsTherapeutic Drug MonitoringToxicity+8 more
University of Geneva, Switzerland 771
Large-scale testing (Phase 3)Study completedNCT00236834
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

Who this might be right for
Nosocomial Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 438
Not applicableUnknownNCT03858387
What this trial is testing

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Who this might be right for
Critical IllnessBacterial Infections
Prince of Songkla University 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524920
What this trial is testing

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria

Who this might be right for
MDR Bacteria
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT01489124
What this trial is testing

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia
Sutep Jaruratanasirikul 9
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Not applicableUnknownNCT06173440
What this trial is testing

Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital

Who this might be right for
Acinetobacter Baumannii
University Hospital, Strasbourg, France 148
Early research (Phase 1)Study completedNCT04493151
What this trial is testing

Imipenem/Cilastatin/Relebactam PK in ECMO

Who this might be right for
Sepsis
Joseph L. Kuti, PharmD 8
Not applicableStudy completedNCT05048693
What this trial is testing

Use of New Antibiotics in Sweden

Who this might be right for
Multi-antibiotic Resistance
Uppsala University 41
Post-approval studies (Phase 4)Study completedNCT02897206
What this trial is testing

Imipenem Prophylaxis in Patients With Acute Pancreatitis

Who this might be right for
Acute Pancreatitis
University Hospital Rijeka 98
Not applicableStudy completedNCT01714570
What this trial is testing

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 123
Early research (Phase 1)Study completedNCT03177720
What this trial is testing

Evaluation of Innovative Tools in Development of Antibiotics

Who this might be right for
Pneumonia
Medical University of Vienna 10
Post-approval studies (Phase 4)Study completedNCT02213783
What this trial is testing

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Who this might be right for
Patients With Febrile Neutropenia
Prince of Songkla University 12
Not applicableUnknownNCT05516433
What this trial is testing

Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria

Who this might be right for
Enterobacteriaceae Infections
Fondation Hôpital Saint-Joseph 100
Large-scale testing (Phase 3)Study completedNCT02452047
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

Who this might be right for
Bacterial Infections
Merck Sharp & Dohme LLC 50
Large-scale testing (Phase 3)UnknownNCT03159078
What this trial is testing

Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens

Who this might be right for
TraumaResistant InfectionCritical Illness
University of Puerto Rico 40
Testing effectiveness (Phase 2)Study completedNCT00515034
What this trial is testing

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 146
Early research (Phase 1)Study completedNCT04147221
What this trial is testing

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Who this might be right for
Sepsis
Hartford Hospital 9
Large-scale testing (Phase 3)Study completedNCT00081744
What this trial is testing

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Who this might be right for
Gram-Positive Bacterial InfectionsCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 850
Load More Results